Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CPIX
#3361
Cumberland Pharmaceuticals Inc
4.9
2
+17.42%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+17.42%
Aylık değişim
+31.20%
6 aylık değişim
+43.02%
Yıllık değişim
-0.61%
Önceki kapanış
4.1
9
Open
4.9
2
Bid
Ask
Low
4.9
2
High
4.9
2
Hacim
7
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
CPIX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
14.92 M
14.84 M
14.4 M
14.18 M
13.97 M
—
Valuation ratios
Enterprise value
19.15 M
42.05 M
13.2 M
7.49 M
14.83 M
127.56 M
Price to earnings ratio
-13.41
-19.46
-6.08
-4.19
-5.15
-54.69
Price to sales ratio
1.19
1.93
0.8
0.67
0.88
4.64
Price to cash flow ratio
8.26
10.97
3.98
4.33
-54.43
-29.07
Price to book ratio
0.95
1.63
0.93
0.89
1.46
2.96
Enterprise value to EBITDA ratio
1.19
2.68
0.66
-1
-7.68
-59.74
Profitability ratios
Return on assets %
-0.03
-0.04
-0.06
-0.08
-0.09
-0.05
Return on equity %
-0.07
-0.08
-0.15
-0.21
-0.29
-0.14
Return on invested capital %
-50.08
-70.83
-53.12
-82.23
-56.35
-25.58
Gross margin %
76.89
75.51
78.29
84.66
82.61
338.4
Operating margin %
-17.04
-21.34
-13.58
-24.16
-16.99
-37.22
EBITDA margin %
43.07
43.63
47.72
-18.87
-5.1
-27.36
Net margin %
-8.92
-9.75
-13.26
-15.88
-17.11
-37.75
Liquidity ratios
Quick ratio
1.53
1.93
1.26
1.11
1.03
4.39
Current ratio
1.95
2.37
1.6
1.28
1.15
4.94
Inventory turnover
0.86
0.92
1
0.84
1.53
1.69
Asset turnover
0.37
0.4
0.47
0.45
0.48
0.58
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.16
0.18
0.17
0.16
0.13
0.37
Long term debt to total equity ratio
0.32
0.35
0.45
0.43
0.45
1.02
Per share metrics
Operating cash flow per share
0.36
0.43
0.58
0.43
-0.04
0.46
EBIT per share
0.75
0.74
1.01
-0.87
-0.49
-0.49
EBITDA per share
1.06
1.05
1.38
-0.52
-0.14
-0.18
Total debt per share
—
—
—
—
—
—
Cash per share
1.63
1.81
1.36
1.28
1.28
4.34
Net current asset value per share
3.3
3.07
3.15
2.5
2.59
8.73
Tangible book value per share
1.19
1.21
0.33
0.43
0.28
2.39
Working capital per share
1.6
1.77
1.19
0.54
0.34
1.61
Book value per share
3.1
2.87
2.49
2.07
1.63
7.08
Haberler
Cumberland Pharmaceuticals hisseleri DMD ilacına FDA’nın hızlı izin vermesiyle yükseldi
Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug
FDA fast tracks Cumberland’s DMD heart disease therapy
Niche Focus & Regulation Shape the Future of Healthcare Firms
Top Research Reports for NVIDIA, Netflix & Merck
Zacks Initiates Coverage of CPIX With Outperform Recommendation
Cumberland, RedHill’in Talicia işinde %30 pay için 4 milyon dolar yatırım yaptı
Cumberland invests $4 million for 30% stake in RedHill’s Talicia business
Cumberland’s injectable ibuprofen receives approval in Mexico
Jones James, Cumberland Pharmaceuticals (CPIX) hisselerinden 861 dolar değerinde satın aldı
Cumberland Pharmaceuticals’in CEO’su Kazimi, CPIX hisselerinden 861 dolar değerinde satın aldı
Caroline Young, Cumberland Pharmaceuticals (CPIX) hisselerinden 397 dolar değerinde satın aldı